NASDAQ: LABT

Lakewood-Amedex Biotherapeutics Inc.

CIK 0002079272 · Pharmaceutical Preparations

Micro by assets Assets $196K as of Jul 5, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

424B3 Filed Jun 22, 2026

Summary not yet generated.

424B3 Filed Jun 22, 2026

Summary not yet generated.

Partner

Trade LABT commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

8-K Filed Jun 17, 2026 · Period ending Jun 15, 2026

Summary not yet generated.

424B3 Filed May 26, 2026

Summary not yet generated.

424B3 Filed May 26, 2026

Summary not yet generated.

10-Q Filed May 22, 2026 · Period ending Mar 31, 2026 Red flag

LABT discloses material control weaknesses, $11.7K cash at quarter-end, $6.8M emergency raise

5 material changes detected. Sign up free to read the summary.

View report

8-K Filed Apr 28, 2026 · Period ending Apr 24, 2026

3 material changes detected. Sign up free to read the summary.

View report